|
Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders Clinical research trials and Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders. Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders clinical trial. Participants oftentimes recieve the finest healthcare available for their Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders  Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
For Condition: Bronchiectasis,Cystic Fibrosis,Pancreatic Insufficiency
Status: Recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: Cystic fibrosis is a disease that affects many parts of the body, particularly the lungs and pancreas. The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of cystic fibrosis. Patients with cystic fibrosis will be asked to participate in this study by undergoing standard medical tests and procedures. Patients will have a history taken and have a physical examination as well as blood tests, and a sweat test (a test for cystic fibrosis of the pancreas in which electrolytes are measured in collected sweat). Patients may also be asked to provide samples of urine, stool, and sputum for additional tests. More complicated procedures such as bronchoscopy or bronchoalveolar lavage may be required for diagnosis, treatment, or research purposes. Patients will receive appropriate treatment with antibiotics, pancreatic enzymes, vitamins, physiotherapy, and other agents. Medications may be given by mouth or injected into a vein. This study will provide patients with information on the prognosis of the disease as well as recommendations for management of cystic fibrosis. In addition this study will provide information to researchers which may be useful in other studies of cystic fibrosis.
Details: This is an omnibus protocol for studying patients with cystic fibrosis and other familial pulmonary and pancreatic disorders. The main purpose of the study is to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis. A well-characterized population of patients with cystic fibrosis will be invited to provide appropriate specimens for laboratory research and to participate in clinical trials of therapeutic agents for cystic fibrosis.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Patients and family members with known or suspected CF and related disorders of the respiratory tract or pancreas as defined by clinical presentation, sweat testing and/or genotyping. Willingness of patients, or guardian to give informed consent. EXCLUSION CRITERIA Age less than 4 years. Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
Total Enrollment: 999
Location and Contact Information:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 870029; 87-DK-0029
Study Start Date: February 18, 1987
Record last reviewed: January 21, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001223
Other Cystic Fibrosis Studies:
1. Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Related Studies:
Other Cystic Fibrosis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
|
|
|
|
|
|
|
|
